Short Interest in Idorsia Ltd (OTCMKTS:IDRSF) Drops By 12.6%

Idorsia Ltd (OTCMKTS:IDRSF) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totalling 6,314,900 shares, a drop of 12.6% from the December 15th total of 7,229,000 shares. Based on an average daily volume of 12,600 shares, the short-interest ratio is presently 501.2 days.

Idorsia Price Performance

IDRSF stock opened at $0.91 on Friday. Idorsia has a 52 week low of $0.70 and a 52 week high of $2.88. The firm has a 50-day simple moving average of $0.98 and a 200-day simple moving average of $1.84.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.